Literature DB >> 15735316

Blood safety and nucleic acid testing in Europe.

S Laperche.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15735316

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  18 in total

1.  Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma Samples.

Authors:  Xavier Bonjoch; Francesc Obispo; Cristina Alemany; Ana Pacha; Esteban Rodríguez; Dolors Xairó
Journal:  Transfus Med Hemother       Date:  2015-04-23       Impact factor: 3.747

2.  Evaluation of hepatitis C virus core antigen assays in detecting recombinant viral antigens of various genotypes.

Authors:  Mohsan Saeed; Ryosuke Suzuki; Madoka Kondo; Hideki Aizaki; Takanobu Kato; Toshiaki Mizuochi; Takaji Wakita; Haruo Watanabe; Tetsuro Suzuki
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

3.  Transfusion-transmissible infections among Serbian blood donors: declining trends over the period 2005-2017.

Authors:  Dušan Vučetić; Milica Jovičić; Irina Maslovarić; Sanja Bogdanović; Ana Antić; Zoran Stanojković; Gorica Filimonović; Vesna Ilić
Journal:  Blood Transfus       Date:  2019-02-19       Impact factor: 3.443

Review 4.  What is the evidence for the change in the blood -donation deferral period for high-risk groups and does it go far enough?

Authors:  Beattie Rh Sturrock; Stuart Mucklow
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

5.  Evaluation of the Procleix Ultrio Elite Assay and the Panther-System for Individual NAT Screening of Blood, Hematopoietic Stem Cell, Tissue and Organ Donors.

Authors:  Albert Heim
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

6.  Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.

Authors:  Syria Laperche; Nadine Le Marrec; Annie Girault; Françoise Bouchardeau; Annabelle Servant-Delmas; Michèle Maniez-Montreuil; Pierre Gallian; Thierry Levayer; Pascal Morel; Nicole Simon
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus.

Authors:  José Eduardo Levi; Ricardo Antonio D'Almeida Pereira; Márcia Bernardino de Carvalho Polite; Mariza Aparecida Mota; Silvia Patricia Nunez; João Renato Rebello Pinho; José Mauro Kutner
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 8.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

Review 9.  New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.

Authors:  Mary C Kuhns; Michael P Busch
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

10.  Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia.

Authors:  Hana Safic Stanic; Ivana Babic; Margareta Maslovic; Vesna Dogic; Jasna Bingulac-Popovic; Manuela Miletic; Nina Jurakovic-Loncar; Tomislav Vuk; Maja Strauss-Patko; Irena Jukic
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.